Published in BMC Res Notes on March 24, 2015
Gene-set Analysis with CGI Information for Differential DNA Methylation Profiling. Sci Rep (2016) 0.75
[Diffuse and calcified nodular opacities]. Pan Afr Med J (2016) 0.75
Sequential model selection-based segmentation to detect DNA copy number variation. Biometrics (2016) 0.75
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med (2002) 21.28
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet (2009) 18.90
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A (2002) 12.68
Genesis: cluster analysis of microarray data. Bioinformatics (2002) 10.50
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med (2008) 10.12
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94
Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A (2010) 7.70
European cancer mortality predictions for the year 2013. Ann Oncol (2013) 2.71
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A (2000) 2.65
Cancer epigenetics. CA Cancer J Clin (2010) 2.16
Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol (2007) 2.10
Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res (2008) 2.03
Allele-specific DNA methylation: beyond imprinting. Hum Mol Genet (2010) 1.98
Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res (2005) 1.81
Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers Prev (2010) 1.74
Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol Cancer (2010) 1.64
Methylation of DNA in cancer. Adv Clin Chem (2010) 1.31
Integrated analyses of copy number variations and gene expression in lung adenocarcinoma. PLoS One (2011) 1.19
An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer. BMC Syst Biol (2010) 1.10
Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis. PLoS Genet (2010) 1.02
Genome-wide epigenetic modifications in cancer. Prog Drug Res (2011) 0.93
Identification of reproducible gene expression signatures in lung adenocarcinoma. BMC Bioinformatics (2013) 0.84
Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells. Med Oncol (2010) 0.84
SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women. J Biomed Sci (2014) 0.84
Moving targets that drive cancer progression. N Engl J Med (2010) 0.80
iGC-an integrated analysis package of gene expression and copy number alteration. BMC Bioinformatics (2017) 0.75